Cargando…
Semireplication-competent vesicular stomatitis virus as a novel platform for oncolytic virotherapy
Among oncolytic viruses, the vesicular stomatitis virus (VSV) is especially potent and a highly promising agent for the treatment of cancer. But, even though effective against multiple tumor entities in preclinical animal models, replication-competent VSV exhibits inherent neurovirulence, which has...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer-Verlag
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3396339/ https://www.ncbi.nlm.nih.gov/pubmed/22286341 http://dx.doi.org/10.1007/s00109-012-0863-6 |